| 发明名称 |
Crystal form |
| 摘要 |
A novel crystalline form of rilapladib, and use thereof in treatment of diseases mediated by Lp-PLA2, is disclosed. |
| 申请公布号 |
US9227953(B2) |
申请公布日期 |
2016.01.05 |
| 申请号 |
US201214241913 |
申请日期 |
2012.08.31 |
| 申请人 |
Glaxo Group Limited |
发明人 |
Lee Mei-yin |
| 分类号 |
C07D211/68;C07D213/70;A61K31/47;C07D401/12 |
主分类号 |
C07D211/68 |
| 代理机构 |
|
代理人 |
Sauermelch Loretta J.;Gimmi Edward R. |
| 主权项 |
1. Crystalline rilapladib characterized by an X-ray powder diffraction pattern substantially in accordance with FIG. 1. |
| 地址 |
Brentford, Middlesex GB |
